Ethos Treatment Management, Ethos Treatment Planning, Ethos Radiotherapy System, Halcyon

The Ethos and Halcyon systems provide a comprehensive solution for radiation therapy, encompassing software for treatment management and adaptive planning, alongside linear accelerators for precise delivery of techniques like IGRT, IMRT, and VMAT. These systems aim to enhance radiotherapy through features like automated plan generation, guided adaptive workflows, and patient motion monitoring, all validated through non-clinical testing for safety and efficacy.

The Ethos and Halcyon systems by Varian Medical Systems comprise a suite of integrated tools designed for comprehensive radiation therapy. This includes Ethos Treatment Management software for managing and monitoring treatment plans and sessions; Ethos Treatment Planning software for generating, modifying, and guiding adaptive radiation therapy plans; and the Ethos Radiotherapy System and Halcyon, which are medical linear accelerators. These linear accelerators are single-energy systems (6 MV Flattening Filter Free) capable of delivering Image Guided Radiation Therapy (IGRT), radiosurgery, Intensity Modulated Radiation Therapy (IMRT), and Volumetric Modulated Arc Therapy (VMAT) for treating lesions, tumors, and other conditions requiring radiation in adult and pediatric patients. Key functionalities of the system include adaptive radiotherapy planning with automated plan generation, guided workflows for treatment sessions, and patient motion monitoring with an extended treatment field area. These represent enhancements aiming to improve treatment precision and workflow efficiency. The systems operate with a dose rate of up to 800 MU/min and integrate components like treatment and imaging consoles, a multi-leaf collimator (MLC), a kV imager, and a patient camera. Non-clinical hardware and software verification and validation testing confirmed conformance to specifications and safety standards, with the software categorized as a "major" level of concern due to potential risks. Electrical safety and electromagnetic compatibility were also verified for the linear accelerators, which concluded the products were safe and effective.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the automated plan generation feature in Ethos Treatment Planning compare to manual planning in terms of plan quality and efficiency for complex cases?; What specific algorithms or technologies are employed for patient motion monitoring in the Ethos Radiotherapy System and Halcyon, and what is their sensitivity and response time?; Can the adaptive radiotherapy capabilities of the Ethos system quantify the dosimetric benefits and potential for toxicity reduction compared to non-adaptive approaches across different tumor sites?; What is the extent of compatibility and data integration between the Ethos Treatment Management, Ethos Treatment Planning, and Ethos Radiotherapy System components, particularly concerning real-time data exchange during adaptive sessions?; Given the "major" level of concern for the software, what specific risk mitigation strategies and fail-safes are implemented to prevent or manage potential software flaws that could impact patient safety?